ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,276.32
-0.13%
Dow Jones
38,655.02
0.22%
US Dollar vs MXN
17.9172
1.21%
Brent Oil
77.745
-0.51%
Bitcoin
70,647.00
2.68%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Abeona Therapeutics Inc (ABEO)

  7. Abeona Therapeutics Inc (ABEO) Noticias

ABEO Abeona Therapeutics Inc

4.435
-0.085 (-1.88%)
Última actualización: 12:38:24
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Abeona Therapeutics Inc ABEO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.085 -1.88% 4.435 12:38:24
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.44 4.38 4.53 4.52
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/6/202406:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
28/5/202406:30GLOBEAbeona Therapeutics to Present at the Jefferies Global..
20/5/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/5/202406:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202406:30EDGAR2Form 8-K - Current report
15/5/202406:30GLOBEAbeona Therapeutics Reports First Quarter 2024 Financial..
13/5/202416:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/5/202414:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/5/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202406:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
03/5/202406:30GLOBEAbeona Therapeutics Announces Pricing of $75 Million..
22/4/202415:05GLOBEAbeona Therapeutics Provides Regulatory Update on Pz-cel
01/4/202407:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/3/202406:30GLOBEAbeona Therapeutics Reports Full Year 2023 Financial Results..
05/3/202406:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
14/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:05GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
01/2/202406:30GLOBEAbeona Therapeutics Announces Progress Update on Pz-cel..
22/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202406:35EDGAR2Form 8-K - Current report
08/1/202406:30GLOBEAbeona Therapeutics Announces $50 Million Credit Facility
15/12/202306:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
04/12/202315:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202306:30EDGAR2Form 8-K - Current report
27/11/202306:30GLOBEAbeona Therapeutics Announces FDA Accepts and Grants..
13/11/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:35EDGAR2Form 8-K - Current report
13/11/202306:30GLOBEAbeona Therapeutics Reports Third Quarter 2023 Financial..
01/11/202306:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/10/202306:30EDGAR2Form 8-K - Current report
17/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202306:30GLOBEAbeona Therapeutics Submits Biologics License Application to..
22/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ABEO
Abeona Therapeutics
TSXV
PAF
NASDAQ
EVERU
Evercore Investment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados